Skip to main content

READYSTATE ASSET MANAGEMENT LP

Position in BSX — Boston Scientific Corp

CIK 1900923 CHICAGO, IL

Position in BSX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$222,135
-$62,649 QoQ
Shares Held
3,540
+25.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
7 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Mar 31, 2026
CallValue
$665,150
CallShares
10,600
PutValue
$665,150
PutShares
10,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

READYSTATE ASSET MANAGEMENT LP holds $35,474,107 across 6 Medical Devices names. BSX ranks #5 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 BSX
Boston Scientific Corp
This page
3,540 $222,135

All Filings in BSX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $665,150 10,600
2026-03-31 $665,150 10,600
2026-03-31 $222,135 3,540
2025-03-31 $2,532,088 25,100
2025-03-31 $3,672,032 36,400
2025-03-31 $284,784 2,823
2024-12-31 $6,868,708 76,900
2024-12-31 $5,243,084 58,700
2024-09-30 $11,631,440 138,800
2024-09-30 $17,556,100 209,500
2024-06-30 $4,759,218 61,800
2024-06-30 $5,406,102 70,200
2024-03-31 $3,129,993 45,700
2024-03-31 $3,945,024 57,600
2023-03-31 $330,198 6,600
2023-03-31 $330,198 6,600